These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7003804)

  • 21. In vivo and in vitro effects of nafazatrom (Bay g 6575), an antithrombotic compound, on arachidonic acid metabolism in platelets and vascular tissue.
    Fischer S; Struppler M; Weber PC
    Biochem Pharmacol; 1983 Jul; 32(14):2231-6. PubMed ID: 6688182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of leukotriene B4 formation in human neutrophils after oral nafazatrom (Bay g 6575).
    Strasser T; Fischer S; Weber PC
    Biochem Pharmacol; 1985 Jun; 34(11):1891-4. PubMed ID: 2988560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin-angiotensin system and prostacyclin biosynthesis in streptozotocin diabetic rats.
    Funakawa S; Okahara T; Imanishi M; Komori T; Yamamoto K; Tochino Y
    Eur J Pharmacol; 1983 Oct; 94(1-2):27-33. PubMed ID: 6360695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of nafazatrom.
    Seuter F; Busse WD
    Thromb Res Suppl; 1983; 4():75-80. PubMed ID: 6415860
    [No Abstract]   [Full Text] [Related]  

  • 25. Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.
    Ambrus JL; Ambrus CM; Gastpar H; Williams P
    J Med; 1982; 13(1-2):35-47. PubMed ID: 6288824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of megavitamin E on prostacyclin and thromboxane synthesis in streptozotocin-induced diabetic rats.
    Gilbert VA; Zebrowski EJ; Chan AC
    Horm Metab Res; 1983 Jul; 15(7):320-5. PubMed ID: 6350138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmented thromboxane generation by mesenteric arteries from pancreatectomized diabetic dogs is coincident with the vascular tone enhancement evoked by Na arachidonate and prostacyclin.
    Sterin-Borda L; Franchi AM; Borda ES; Del Castillo E; Gimeno MF; Gimeno AL
    Eur J Pharmacol; 1984 Aug; 103(3-4):211-21. PubMed ID: 6436040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased plasma prostacyclin-regenerating activities in diabetics.
    Sensaki S; Okuma M; Uchino H
    Prostaglandins Leukot Med; 1985 Nov; 20(2):197-207. PubMed ID: 3906672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simulating the diabetic environment modifies in vitro prostacyclin synthesis.
    Jeremy JY; Mikhailidis DP; Dandona P
    Diabetes; 1983 Mar; 32(3):217-21. PubMed ID: 6337900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormality in prostacyclin-stimulatory activity in sera from diabetics.
    Inoguchi T; Umeda F; Ono H; Kunisaki M; Watanabe J; Nawata H
    Metabolism; 1989 Sep; 38(9):837-42. PubMed ID: 2505015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating prostacyclin and thromboxane levels in patients with diabetic retinopathy.
    Lane LS; Jansen PD; Lahav M; Rudy C
    Ophthalmology; 1982 Jul; 89(7):763-6. PubMed ID: 6750495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of prostaglandins E2, I2 and F2 alpha on the tone of isolated coronary arteries from alloxan-diabetic dogs.
    Palik I; Koltai MZ; Hadházy P; Malomvölgyi B; Wagner M; Pogátsa G
    Prostaglandins Leukot Med; 1982 Jun; 8(6):607-14. PubMed ID: 7051047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonging prostacyclin production by nafazatrom or dipyridamole.
    Deckmyn H; Gresele P; Arnout J; Todisco A; Vermylen J
    Lancet; 1984 Aug; 2(8399):410-1. PubMed ID: 6147492
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of experimental diabetes on prostacyclin production by tissues from pregnant rats.
    El Tahir KE; Williams KI; Betteridge DJ
    Prostaglandins Leukot Med; 1982 May; 8(5):429-35. PubMed ID: 7048333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone. Requirement for peroxidative metabolism.
    Reed GA; Griffin IO; Eling TE
    Mol Pharmacol; 1985 Jan; 27(1):109-14. PubMed ID: 3917545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-induced release of prostacyclin (PGI2) into circulation of anaesthetized cats.
    Swies J; Radomski M; Gryglewski RJ
    Pharmacol Res Commun; 1979 Sep; 11(8):649-55. PubMed ID: 390552
    [No Abstract]   [Full Text] [Related]  

  • 37. Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatrom.
    Deckmyn H; Van Houtte E; Verstraete M; Vermylen J
    Biochem Pharmacol; 1983 Sep; 32(18):2757-62. PubMed ID: 6578796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disappearance of prostacyclin (PGI2) in the circulation of the dog [proceedings].
    Dusting GJ; Moncada S; Vane JR
    Br J Pharmacol; 1978 Mar; 62(3):414P-415P. PubMed ID: 346132
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathogenesis of cardiovascular disorders in streptozotocin-induced diabetes in rat. II. Correlation between lipid peroxides, thromboxane A2/prostacyclin, and platelet aggregation in different stages of diabetes.
    Somova L; Kamenov V; Doncheva M; Kirilov G; Vassileva M
    Acta Physiol Pharmacol Bulg; 1988; 14(3):57-62. PubMed ID: 3066112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An extract of Pueraria tuberosa tubers attenuates diabetic nephropathy by upregulating matrix metalloproteinase-9 expression in the kidney of diabetic rats.
    Tripathi YB; Shukla R; Pandey N; Pandey V; Kumar M
    J Diabetes; 2017 Feb; 9(2):123-132. PubMed ID: 26924185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.